Loading...
Loading...
Indian Pharmaceutical Exporter Β· #3 for Docetaxel Β· $900.0K export value Β· DGFT Verified
Kwality Pharmaceuticals Limited is the #3 Indian exporter of Docetaxel with $900.0K in export value and 18 verified shipments. Kwality Pharmaceuticals Limited holds a 2.3% market share in Docetaxel exports across 10 countries. The company exports 20 pharmaceutical products worth $5.6M across 11 therapeutic categories.

| Country | Value | Shipments | Share |
|---|---|---|---|
| AFGHANISTAN | $123.4K | 3 | 48.3% |
| PERU | $72.6K | 3 | 28.5% |
| MOZAMBIQUE | $22.6K | 1 | 8.9% |
| TURKEY | $9.4K | 2 | 3.7% |
| NIGERIA | $6.1K | 2 | 2.4% |
| ST KITTS-NEVIS-ANGUILLA | $6.0K | 2 | 2.3% |
| MYANMAR | $5.9K | 1 | 2.3% |
| MALI | $5.6K | 2 | 2.2% |
| NICARAGUA | $3.7K | 1 | 1.5% |
| BRAZIL | $0 | 1 | 0.0% |
Kwality Pharmaceuticals Limited exports Docetaxel to 10 countries. The largest destination is AFGHANISTAN accounting for 48.3% of Kwality Pharmaceuticals Limited's Docetaxel shipments, followed by PERU (28.5%) and MOZAMBIQUE (8.9%). These destinations reflect Kwality Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TRUST ANESTHETIC LTD | AFGHANISTAN | $123.4K | 3 |
| DS PHARMA PERU S.A.C. | PERU | $72.6K | 3 |
| FARMA HOLDING SA | MOZAMBIQUE | $22.6K | 1 |
| SLO TIBBI ILAC ITHALAT | TURKEY | $9.4K | 2 |
| DOMAKS INVESTMENTS LIMITED | NIGERIA | $6.1K | 2 |
| CENTRAL MEDICAL STORES | ST KITTS-NEVIS-ANGUILLA | $6.0K | 2 |
India exported $22.4M worth of Docetaxel through 2,634 shipments from 253 suppliers to 120 countries, serving 641 buyers globally. Kwality Pharmaceuticals Limited contributes $900.0K to this total, accounting for 2.3% of India's Docetaxel exports. Kwality Pharmaceuticals Limited ships Docetaxel to 10 countries through 11 buyers.
Kwality Pharmaceuticals Limited's average Docetaxel shipment value is $50.0K per consignment, based on 18 shipments totaling $900.0K. The largest destination is AFGHANISTAN (48.3% of Kwality Pharmaceuticals Limited's Docetaxel exports).
Kwality Pharmaceuticals Limited ranks #3 among 253 Indian Docetaxel exporters with a 2.3% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($8.4M), MYLAN LABORATORIES LIMITED ($3.5M), INTAS PHARMACEUTICALS LIMITED ($2.2M). Kwality Pharmaceuticals Limited processed 18 shipments to 10 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DOCETAXEL INJECTION USP 80MG/2ML SOLVENT | $129.3K | 4 |
| Docetaxel Injection USP 80mg/2ml (BATCHNO & OTHER DETAILS AS PER INV & PACKINGLIST) | $49.8K | 2 |
| Docetaxel Injection USP 80mg/2ml (Batchno & other details as per inv & packinglist) | $22.9K | 1 |
| DOCETAXEL INJECTION USP 80MG/2ML & SOLVE | $22.6K | 1 |
| DOCETAXEL INJECTION USP 80MG/2ML (BATCH | $11.4K | 3 |
| DOCETAXEL INJECTION USP 80MG/2ML BATCH | $5.9K | 2 |
| DOCETAXEL INJECTION USP 80MG 2ML BATCHNO OTHER DETAIL AS PER INV PACKING LIST | $4.5K | 1 |
| DOCETAXEL INJECTION USP 80 MG/2 ML (40 M | $3.0K | 1 |
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | EUGIA PHARMA SPECIALITIES LIMITED | $1.1M | 88 | 2 | $12.6K |
| 9 | NV REMEDIES PRIVATE LIMITED | $959.1K | 27 | 4 | $35.5K |
| 3 | KWALITY PHARMACEUTICALS LIMITED β | $900.0K | 18 | 10 | $50.0K |
| 10 | VENUS REMEDIES LIMITED | $829.1K |
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 530 | 20.1% |
| DELHI AIR | 416 | 15.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 379 | 14.4% |
| SAHAR AIR | 372 | 14.1% |
| Bombay Air | 132 | 5.0% |
| Delhi Air | 90 | 3.4% |
| HYDERABAD AIR | 79 | 3.0% |
| HYDERABAD ACC (INHYD4) | 54 | 2.1% |
Kwality Pharmaceuticals Limited also exports these oncology products. Each links to the detailed product page.
Kwality Pharmaceuticals Limited exports 20 products worth $5.6M. Beyond Docetaxel, top products include Caffeine, Hydrocortisone, Imipenem, Amikacin, Cyclophosphamide. View the complete Kwality Pharmaceuticals Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Docetaxel β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Kwality Pharmaceuticals Limited's Docetaxel exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Kwality Pharmaceuticals Limited
Full Company Profile β
20 products Β· $5.6M total trade Β· 11 categories
| DIRECTORATE OF PROCUREMENT |
| MYANMAR |
| $5.9K |
| 1 |
| GENERIC PHARMA (G.P.) S.A | NICARAGUA | $3.7K | 1 |
| PHARMA PLUS MALI, S.A. | MALI | $2.9K | 1 |
| PHARMA PLUS MALI S A | MALI | $2.8K | 1 |
Kwality Pharmaceuticals Limited supplies Docetaxel to 11 buyers globally. The largest buyer is TRUST ANESTHETIC LTD (AFGHANISTAN), followed by DS PHARMA PERU S.A.C. (PERU) and FARMA HOLDING SA (MOZAMBIQUE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| DOCETAXEL INJECTION 80MG/2ML WITH SOLVEN |
| $3.0K |
| 1 |
| DOCETAXEL INJECTION USP 120MG/3ML BATCH | $2.9K | 1 |
Kwality Pharmaceuticals Limited exports 11 distinct Docetaxel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DOCETAXEL INJECTION USP 80MG/2ML SOLVENT with 4 shipments worth $129.3K.
| 97 |
| 16 |
| $8.5K |
| 11 | VEXXA LIFESCIENCES PVT. LTD. | $817.5K | 64 | 2 | $12.8K |
Kwality Pharmaceuticals Limited ranks #3 among 253 Indian Docetaxel exporters. Average shipment value of $50.0K compared to the market average of $88.6K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and NV REMEDIES PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 120+ countries, 641+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Kwality Pharmaceuticals Limited.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Docetaxel. For current shipment-level data, contact TransData Nexus.